ID   CXAR_HUMAN              Reviewed;         365 AA.
AC   P78310; B2R8V8; B7WPI3; D3YHP0; O00694; Q8WWT6; Q8WWT7; Q8WWT8; Q9UKV4;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   03-AUG-2022, entry version 213.
DE   RecName: Full=Coxsackievirus and adenovirus receptor;
DE            Short=CAR;
DE            Short=hCAR;
DE   AltName: Full=CVB3-binding protein;
DE   AltName: Full=Coxsackievirus B-adenovirus receptor;
DE   AltName: Full=HCVADR;
DE   Flags: Precursor;
GN   Name=CXADR; Synonyms=CAR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION AS A VIRUS RECEPTOR, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=9096397; DOI=10.1073/pnas.94.7.3352;
RA   Tomko R.P., Xu R., Philipson L.;
RT   "HCAR and MCAR: the human and mouse cellular receptors for subgroup C
RT   adenoviruses and group B coxsackieviruses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:3352-3356(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9036860; DOI=10.1126/science.275.5304.1320;
RA   Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E., Krithivas A.,
RA   Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W.;
RT   "Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2
RT   and 5.";
RL   Science 275:1320-1323(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10543405; DOI=10.1007/s004399900136;
RA   Bowles K.R., Gibson J., Wu J., Shaffer L.G., Towbin J.A., Bowles N.E.;
RT   "Genomic organization and chromosomal localization of the human
RT   Coxsackievirus B-adenovirus receptor gene.";
RL   Hum. Genet. 105:354-359(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11573093; DOI=10.1038/nsb1001-874;
RA   He Y., Chipman P.R., Howitt J., Bator C.M., Whitt M.A., Baker T.S.,
RA   Kuhn R.J., Anderson C.W., Freimuth P., Rossmann M.G.;
RT   "Interaction of coxsackievirus B3 with the full length coxsackievirus-
RT   adenovirus receptor.";
RL   Nat. Struct. Biol. 8:874-878(2001).
RN   [5]
RP   FUNCTION (MICROBIAL INFECTION), NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4
RP   AND 5), INTERACTION WITH COXSACKIEVIRUS TYPE B3, AND SUBCELLULAR LOCATION.
RX   PubMed=14978041; DOI=10.1074/jbc.m311754200;
RA   Doerner A., Xiong D., Couch K., Yajima T., Knowlton K.U.;
RT   "Alternatively spliced soluble coxsackie-adenovirus receptors inhibit
RT   coxsackievirus infection.";
RL   J. Biol. Chem. 279:18497-18503(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Andersson B., Tomko R.P., Andersson K., Darban H., Oncu D., Mizra M.,
RA   Sollerbrant K., Sonnhammer E., Philipson L.;
RT   "Putative regulatory domains in the human and mouse CAR genes.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RA   Dietel M.;
RT   "Identification and characterisation of CAR 4/6 as a new splice variant of
RT   the Coxsackie adenovirus receptor (CAR).";
RL   Submitted (JAN-2010) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cervix;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10490761; DOI=10.1038/sj.gt.3301030;
RA   Fechner H., Haack A., Wang H., Wang X., Eizema K., Pauschinger M.,
RA   Schoemaker R.G., van Veghel R., Houtsmuller A.B., Schultheiss H.-P.,
RA   Lamers J.M.J., Poller W.;
RT   "Expression of Coxsackie-adenovirus-receptor and alpha v-integrin does not
RT   correlate with adenovector targeting in vivo indicating anatomical vector
RT   barriers.";
RL   Gene Ther. 6:1520-1535(1999).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN ADENOVIRUS
RP   SUBGROUPS A/C/D/E/F FIBER PROTEINS.
RX   PubMed=9733828; DOI=10.1128/jvi.72.10.7909-7915.1998;
RA   Roelvink P.W., Lizonova A., Lee J.G.M., Li Y., Bergelson J.M.,
RA   Finberg R.W., Brough D.E., Kovesdi I., Wickham T.J.;
RT   "The coxsackievirus-adenovirus receptor protein can function as a cellular
RT   attachment protein for adenovirus serotypes from subgroups A, C, D, E, and
RT   F.";
RL   J. Virol. 72:7909-7915(1998).
RN   [16]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH HUMAN ADENOVIRUS FIBER
RP   PROTEIN, AND MUTAGENESIS OF 70-VAL--ILE-72.
RX   PubMed=10666333; DOI=10.1006/excr.1999.4761;
RA   Tomko R.P., Johansson C.B., Totrov M., Abagyan R., Frisen J., Philipson L.;
RT   "Expression of the adenovirus receptor and its interaction with the fiber
RT   knob.";
RL   Exp. Cell Res. 255:47-55(2000).
RN   [17]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS GROUP B
RP   CAPSID PROTEINS.
RX   PubMed=10814575; DOI=10.1006/viro.2000.0324;
RA   Martino T.A., Petric M., Weingartl H., Bergelson J.M., Opavsky M.A.,
RA   Richardson C.D., Modlin J.F., Finberg R.W., Kain K.C., Willis N.,
RA   Gauntt C.J., Liu P.P.;
RT   "The coxsackie-adenovirus receptor (CAR) is used by reference strains and
RT   clinical isolates representing all six serotypes of coxsackievirus group B
RT   and by swine vesicular disease virus.";
RL   Virology 271:99-108(2000).
RN   [18]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=11549277; DOI=10.1006/bbrc.2001.5535;
RA   Thoelen I., Magnusson C., Tagerud S., Polacek C., Lindberg M.,
RA   Van Ranst M.;
RT   "Identification of alternative splice products encoded by the human
RT   coxsackie-adenovirus receptor gene.";
RL   Biochem. Biophys. Res. Commun. 287:216-222(2001).
RN   [19]
RP   TISSUE SPECIFICITY.
RX   PubMed=11457744; DOI=10.1161/01.cir.104.3.275;
RA   Noutsias M., Fechner H., de Jonge H., Wang X., Dekkers D.,
RA   Houtsmuller A.B., Pauschinger M., Bergelson J.M., Warraich R., Yacoub M.,
RA   Hetzer R., Lamers J.M.J., Schultheiss H.-P., Poller W.;
RT   "Human coxsackie-adenovirus receptor is colocalized with integrins
RT   alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and
RT   upregulated in dilated cardiomyopathy: implications for cardiotropic viral
RT   infections.";
RL   Circulation 104:275-280(2001).
RN   [20]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF TYR-318 AND 345-LEU--MET-348.
RX   PubMed=11316797; DOI=10.1074/jbc.m009531200;
RA   Cohen C.J., Gaetz J., Ohman T., Bergelson J.M.;
RT   "Multiple regions within the coxsackievirus and adenovirus receptor
RT   cytoplasmic domain are required for basolateral sorting.";
RL   J. Biol. Chem. 276:25392-25398(2001).
RN   [21]
RP   SUBCELLULAR LOCATION, INTERACTION WITH TJP1, AND FUNCTION.
RX   PubMed=11734628; DOI=10.1073/pnas.261452898;
RA   Cohen C.J., Shieh J.T.C., Pickles R.J., Okegawa T., Hsieh J.-T.,
RA   Bergelson J.M.;
RT   "The coxsackievirus and adenovirus receptor is a transmembrane component of
RT   the tight junction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:15191-15196(2001).
RN   [22]
RP   FUNCTION (MICROBIAL INFECTION), SUBCELLULAR LOCATION, INTERACTION WITH
RP   CTNNB1, AND INTERACTION WITH HUMAN ADENOVIRUS FIBER PROTEIN.
RX   PubMed=12297051; DOI=10.1016/s0092-8674(02)00912-1;
RA   Walters R.W., Freimuth P., Moninger T.O., Ganske I., Zabner J., Welsh M.J.;
RT   "Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing
RT   virus escape.";
RL   Cell 110:789-799(2002).
RN   [23]
RP   PALMITOYLATION AT CYS-259 AND CYS-260, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 259-CYS-CYS-260.
RX   PubMed=12021372; DOI=10.1128/jvi.76.12.6382-6386.2002;
RA   van't Hof W., Crystal R.G.;
RT   "Fatty acid modification of the coxsackievirus and adenovirus receptor.";
RL   J. Virol. 76:6382-6386(2002).
RN   [24]
RP   INTERACTION WITH LNX.
RX   PubMed=12468544; DOI=10.1074/jbc.m205927200;
RA   Sollerbrant K., Raschperger E., Mirza M., Engstroem U., Philipson L.,
RA   Ljungdahl P.O., Pettersson R.F.;
RT   "The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the
RT   PDZ domain-containing protein ligand-of-numb protein-X (LNX).";
RL   J. Biol. Chem. 278:7439-7444(2003).
RN   [25]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY (ISOFORMS 1 AND 2).
RX   PubMed=15533241; DOI=10.1186/1471-2121-5-42;
RA   Shaw C.A., Holland P.C., Sinnreich M., Allen C., Sollerbrant K.,
RA   Karpati G., Nalbantoglu J.;
RT   "Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR)
RT   in neuromuscular junction and cardiac intercalated discs.";
RL   BMC Cell Biol. 5:42-42(2004).
RN   [26]
RP   INTERACTION WITH MPDZ, AND SUBCELLULAR LOCATION.
RX   PubMed=15364909; DOI=10.1074/jbc.m409061200;
RA   Coyne C.B., Voelker T., Pichla S.L., Bergelson J.M.;
RT   "The coxsackievirus and adenovirus receptor interacts with the multi-PDZ
RT   domain protein-1 (MUPP-1) within the tight junction.";
RL   J. Biol. Chem. 279:48079-48084(2004).
RN   [27]
RP   INTERACTION WITH MAGI1; DLG4 AND PRKCABP.
RX   PubMed=15304526; DOI=10.1242/jcs.01300;
RA   Ashbourne-Excoffon K.J.D., Hruska-Hageman A.M., Klotz M., Traver G.L.,
RA   Zabner J.;
RT   "A role for the PDZ-binding domain of the coxsackie B virus and adenovirus
RT   receptor (CAR) in cell adhesion and growth.";
RL   J. Cell Sci. 117:4401-4409(2004).
RN   [28]
RP   INTERACTION WITH JAML, DOMAIN, AND FUNCTION.
RX   PubMed=15800062; DOI=10.1091/mbc.e05-01-0036;
RA   Zen K., Liu Y., McCall I.C., Wu T., Lee W., Babbin B.A., Nusrat A.,
RA   Parkos C.A.;
RT   "Neutrophil migration across tight junctions is mediated by adhesive
RT   interactions between epithelial CAR and a JAM-like protein on
RT   neutrophils.";
RL   Mol. Biol. Cell 16:2694-2703(2005).
RN   [29]
RP   FUNCTION IN LEUKOCYTE MIGRATION, AND INTERACTION WITH JAML.
RX   PubMed=19064666; DOI=10.1083/jcb.200805061;
RA   Luissint A.C., Lutz P.G., Calderwood D.A., Couraud P.O., Bourdoulous S.;
RT   "JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis
RT   by alpha4beta1 integrin activation.";
RL   J. Cell Biol. 183:1159-1173(2008).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-323 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 21-144 IN COMPLEX WITH HUMAN
RP   ADENOVIRUS 12 FIBER PROTEIN, AND DISULFIDE BONDS.
RX   PubMed=10567268; DOI=10.1126/science.286.5444.1579;
RA   Bewley M.C., Springer K., Zhang Y.-B., Freimuth P., Flanagan J.M.;
RT   "Structural analysis of the mechanism of adenovirus binding to its human
RT   cellular receptor, CAR.";
RL   Science 286:1579-1583(1999).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 15-140, DOMAIN, AND DISULFIDE
RP   BOND.
RX   PubMed=11080637; DOI=10.1016/s0969-2126(00)00528-1;
RA   van Raaij M.J., Chouin E., van der Zandt H., Bergelson J.M., Cusack S.;
RT   "Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain
RT   at 1.7 A resolution.";
RL   Structure 8:1147-1155(2000).
RN   [37]
RP   STRUCTURE BY NMR OF 21-144, AND DISULFIDE BONDS.
RX   PubMed=14967025; DOI=10.1021/bi035490x;
RA   Jiang S., Jacobs A., Laue T.M., Caffrey M.;
RT   "Solution structure of the coxsackievirus and adenovirus receptor domain
RT   1.";
RL   Biochemistry 43:1847-1853(2004).
CC   -!- FUNCTION: Component of the epithelial apical junction complex that may
CC       function as a homophilic cell adhesion molecule and is essential for
CC       tight junction integrity. Also involved in transepithelial migration of
CC       leukocytes through adhesive interactions with JAML a transmembrane
CC       protein of the plasma membrane of leukocytes. The interaction between
CC       both receptors also mediates the activation of gamma-delta T-cells, a
CC       subpopulation of T-cells residing in epithelia and involved in tissue
CC       homeostasis and repair. Upon epithelial CXADR-binding, JAML induces
CC       downstream cell signaling events in gamma-delta T-cells through PI3-
CC       kinase and MAP kinases. It results in proliferation and production of
CC       cytokines and growth factors by T-cells that in turn stimulate
CC       epithelial tissues repair. {ECO:0000269|PubMed:11734628,
CC       ECO:0000269|PubMed:12297051, ECO:0000269|PubMed:15800062,
CC       ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:9096397}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for adenovirus type
CC       C. {ECO:0000269|PubMed:10567268, ECO:0000269|PubMed:10666333,
CC       ECO:0000269|PubMed:12297051, ECO:0000269|PubMed:9733828}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for Coxsackievirus
CC       B1 to B6. {ECO:0000269|PubMed:10814575, ECO:0000269|PubMed:14978041}.
CC   -!- SUBUNIT: Monomer. May form homodimer. Interacts with LNX, MAGI1, DLG4,
CC       PRKCABP, TJP1 and CTNNB1. Interacts with MPDZ; recruits MPDZ to
CC       intercellular contact sites. Interacts with JAML (homodimeric form).
CC       Secreted isoform 3, isoform 4 and isoform 5 can interact with the
CC       extracellular domain of the receptor. {ECO:0000269|PubMed:11734628,
CC       ECO:0000269|PubMed:12468544, ECO:0000269|PubMed:15304526,
CC       ECO:0000269|PubMed:15364909, ECO:0000269|PubMed:15800062,
CC       ECO:0000269|PubMed:19064666}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with adenovirus subgroups A,
CC       C, D, E and F fiber proteins as well as coxsackievirus B1, B2, B3, B4,
CC       B5 and B6 capsid proteins (PubMed:14978041, PubMed:9733828,
CC       PubMed:10666333, PubMed:10814575, PubMed:12297051, PubMed:10567268).
CC       {ECO:0000269|PubMed:10567268, ECO:0000269|PubMed:10666333,
CC       ECO:0000269|PubMed:10814575, ECO:0000269|PubMed:12297051,
CC       ECO:0000269|PubMed:14978041, ECO:0000269|PubMed:9733828}.
CC   -!- INTERACTION:
CC       P78310; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-747931, EBI-12109402;
CC       P78310; Q92520: FAM3C; NbExp=3; IntAct=EBI-747931, EBI-2876774;
CC       P78310; P21145: MAL; NbExp=3; IntAct=EBI-747931, EBI-3932027;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:15533241}; Single-pass type I membrane protein
CC       {ECO:0000255}. Basolateral cell membrane {ECO:0000269|PubMed:11316797,
CC       ECO:0000269|PubMed:12021372, ECO:0000269|PubMed:12297051,
CC       ECO:0000269|PubMed:15364909}; Single-pass type I membrane protein
CC       {ECO:0000255}. Cell junction, tight junction
CC       {ECO:0000269|PubMed:11734628, ECO:0000269|PubMed:12297051}. Cell
CC       junction, adherens junction {ECO:0000269|PubMed:12297051}. Note=In
CC       epithelial cells localizes to the apical junction complex composed of
CC       tight and adherens junctions (PubMed:12297051). In airway epithelial
CC       cells localized to basolateral membrane but not to apical surface
CC       (PubMed:11316797). {ECO:0000269|PubMed:11316797,
CC       ECO:0000269|PubMed:12297051}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted
CC       {ECO:0000269|PubMed:14978041}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Secreted
CC       {ECO:0000269|PubMed:14978041}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Secreted
CC       {ECO:0000269|PubMed:14978041}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=SIV;
CC         IsoId=P78310-1; Sequence=Displayed;
CC       Name=2; Synonyms=CAR2, HCAR2, TVV;
CC         IsoId=P78310-2; Sequence=VSP_014825, VSP_014826;
CC       Name=3; Synonyms=CAR2/7, Gamma;
CC         IsoId=P78310-3; Sequence=VSP_014819, VSP_014820;
CC       Name=4; Synonyms=CAR3/7;
CC         IsoId=P78310-4; Sequence=VSP_014821, VSP_014822;
CC       Name=5; Synonyms=CAR4/7, Beta;
CC         IsoId=P78310-5; Sequence=VSP_014823, VSP_014824;
CC       Name=6;
CC         IsoId=P78310-6; Sequence=VSP_047357;
CC       Name=7; Synonyms=CAR 4/6;
CC         IsoId=P78310-7; Sequence=VSP_047729;
CC   -!- TISSUE SPECIFICITY: Expressed in pancreas, brain, heart, small
CC       intestine, testis, prostate and at a lower level in liver and lung.
CC       Isoform 5 is ubiquitously expressed. Isoform 3 is expressed in heart,
CC       lung and pancreas. In skeletal muscle, isoform 1 is found at the
CC       neuromuscular junction and isoform 2 is found in blood vessels. In
CC       cardiac muscle, isoform 1 and isoform 2 are found at intercalated
CC       disks. In heart expressed in subendothelial layers of the vessel wall
CC       but not in the luminal endothelial surface. Expression is elevated in
CC       hearts with dilated cardiomyopathy. {ECO:0000269|PubMed:10490761,
CC       ECO:0000269|PubMed:11457744, ECO:0000269|PubMed:11549277,
CC       ECO:0000269|PubMed:9096397}.
CC   -!- DOMAIN: The Ig-like C2-type 1 domain mediates homodimerization and
CC       interaction with JAML.
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with MPDZ and MAGI1.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: Palmitoylated on Cys-259 and/or Cys-260; required for proper
CC       localization to the plasma membrane. {ECO:0000269|PubMed:12021372}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U90716; AAC51234.1; -; mRNA.
DR   EMBL; Y07593; CAA68868.1; -; mRNA.
DR   EMBL; AF169366; AAF05908.1; -; Genomic_DNA.
DR   EMBL; AF169360; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF169361; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF169362; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF169363; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF169364; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF169365; AAF05908.1; JOINED; Genomic_DNA.
DR   EMBL; AF200465; AAF24344.1; -; Genomic_DNA.
DR   EMBL; AY072910; AAL68878.1; -; mRNA.
DR   EMBL; AY072911; AAL68879.1; -; mRNA.
DR   EMBL; AY072912; AAL68880.1; -; mRNA.
DR   EMBL; AF242865; AAG01088.1; -; Genomic_DNA.
DR   EMBL; AF242862; AAG01088.1; JOINED; Genomic_DNA.
DR   EMBL; AF242864; AAG01088.1; JOINED; Genomic_DNA.
DR   EMBL; GU474812; ADC84500.1; -; mRNA.
DR   EMBL; CR617256; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BT019876; AAV38679.1; -; mRNA.
DR   EMBL; AK313526; BAG36305.1; -; mRNA.
DR   EMBL; AP000963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000967; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX10031.1; -; Genomic_DNA.
DR   EMBL; BC003684; AAH03684.1; -; mRNA.
DR   EMBL; BC010536; AAH10536.1; -; mRNA.
DR   EMBL; AF124598; AAD31772.1; -; mRNA.
DR   CCDS; CCDS33519.1; -. [P78310-1]
DR   CCDS; CCDS56204.1; -. [P78310-6]
DR   CCDS; CCDS56205.1; -. [P78310-5]
DR   CCDS; CCDS56206.1; -. [P78310-4]
DR   CCDS; CCDS56207.1; -. [P78310-3]
DR   RefSeq; NP_001193992.1; NM_001207063.1. [P78310-5]
DR   RefSeq; NP_001193993.1; NM_001207064.1. [P78310-4]
DR   RefSeq; NP_001193994.1; NM_001207065.1. [P78310-3]
DR   RefSeq; NP_001193995.1; NM_001207066.1. [P78310-6]
DR   RefSeq; NP_001329.1; NM_001338.4. [P78310-1]
DR   RefSeq; XP_011527781.1; XM_011529479.1. [P78310-5]
DR   PDB; 1EAJ; X-ray; 1.35 A; A/B=15-140.
DR   PDB; 1F5W; X-ray; 1.70 A; A/B=15-140.
DR   PDB; 1JEW; EM; 22.00 A; R=21-140.
DR   PDB; 1KAC; X-ray; 2.60 A; B=22-144.
DR   PDB; 1P69; X-ray; 3.10 A; B=22-144.
DR   PDB; 1P6A; X-ray; 2.90 A; B=22-144.
DR   PDB; 1RSF; NMR; -; A=21-144.
DR   PDB; 2J12; X-ray; 1.50 A; B=15-140.
DR   PDB; 2J1K; X-ray; 2.30 A; A/B/G/J/K/O/P/T/V/X/Y/Z=15-140.
DR   PDB; 2NPL; NMR; -; X=142-235.
DR   PDB; 2W9L; X-ray; 2.91 A; A/B/G/J/K/O/P/T/V/X/Y/Z=16-139.
DR   PDB; 2WBW; X-ray; 1.55 A; B=15-138.
DR   PDB; 3J6L; EM; 9.00 A; B=15-140.
DR   PDB; 3J6M; EM; 9.00 A; B=22-144.
DR   PDB; 3J6N; EM; 9.00 A; K=20-233.
DR   PDB; 3J6O; EM; 9.00 A; S=20-236.
DR   PDB; 7DPZ; EM; 3.80 A; K=20-140.
DR   PDB; 7DQ1; EM; 3.60 A; K=20-140.
DR   PDB; 7VXZ; EM; 3.19 A; E=20-236.
DR   PDB; 7VYK; EM; 2.79 A; E=20-236.
DR   PDB; 7VYL; EM; 2.79 A; E=20-236.
DR   PDB; 7VYM; EM; 3.68 A; E=20-236.
DR   PDB; 7W14; EM; 2.20 A; E=20-236.
DR   PDBsum; 1EAJ; -.
DR   PDBsum; 1F5W; -.
DR   PDBsum; 1JEW; -.
DR   PDBsum; 1KAC; -.
DR   PDBsum; 1P69; -.
DR   PDBsum; 1P6A; -.
DR   PDBsum; 1RSF; -.
DR   PDBsum; 2J12; -.
DR   PDBsum; 2J1K; -.
DR   PDBsum; 2NPL; -.
DR   PDBsum; 2W9L; -.
DR   PDBsum; 2WBW; -.
DR   PDBsum; 3J6L; -.
DR   PDBsum; 3J6M; -.
DR   PDBsum; 3J6N; -.
DR   PDBsum; 3J6O; -.
DR   PDBsum; 7DPZ; -.
DR   PDBsum; 7DQ1; -.
DR   PDBsum; 7VXZ; -.
DR   PDBsum; 7VYK; -.
DR   PDBsum; 7VYL; -.
DR   PDBsum; 7VYM; -.
DR   PDBsum; 7W14; -.
DR   AlphaFoldDB; P78310; -.
DR   BMRB; P78310; -.
DR   SMR; P78310; -.
DR   BioGRID; 107905; 354.
DR   IntAct; P78310; 21.
DR   MINT; P78310; -.
DR   STRING; 9606.ENSP00000284878; -.
DR   TCDB; 8.A.23.1.14; the basigin (basigin) family.
DR   UniLectin; P78310; -.
DR   GlyConnect; 1159; 1 N-Linked glycan (1 site).
DR   GlyGen; P78310; 3 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; P78310; -.
DR   PhosphoSitePlus; P78310; -.
DR   SwissPalm; P78310; -.
DR   BioMuta; CXADR; -.
DR   DMDM; 6685351; -.
DR   EPD; P78310; -.
DR   jPOST; P78310; -.
DR   MassIVE; P78310; -.
DR   MaxQB; P78310; -.
DR   PaxDb; P78310; -.
DR   PeptideAtlas; P78310; -.
DR   PRIDE; P78310; -.
DR   ProteomicsDB; 12784; -.
DR   ProteomicsDB; 57548; -. [P78310-1]
DR   ProteomicsDB; 57549; -. [P78310-2]
DR   ProteomicsDB; 57550; -. [P78310-3]
DR   ProteomicsDB; 57551; -. [P78310-4]
DR   ProteomicsDB; 57552; -. [P78310-5]
DR   ProteomicsDB; 6303; -.
DR   Antibodypedia; 1120; 486 antibodies from 39 providers.
DR   DNASU; 1525; -.
DR   Ensembl; ENST00000284878.12; ENSP00000284878.7; ENSG00000154639.19. [P78310-1]
DR   Ensembl; ENST00000356275.10; ENSP00000348620.6; ENSG00000154639.19. [P78310-3]
DR   Ensembl; ENST00000400165.5; ENSP00000383029.1; ENSG00000154639.19. [P78310-4]
DR   Ensembl; ENST00000400166.5; ENSP00000383030.1; ENSG00000154639.19. [P78310-5]
DR   Ensembl; ENST00000400169.1; ENSP00000383033.1; ENSG00000154639.19. [P78310-6]
DR   GeneID; 1525; -.
DR   KEGG; hsa:1525; -.
DR   MANE-Select; ENST00000284878.12; ENSP00000284878.7; NM_001338.5; NP_001329.1.
DR   UCSC; uc002ykh.3; human. [P78310-1]
DR   CTD; 1525; -.
DR   DisGeNET; 1525; -.
DR   GeneCards; CXADR; -.
DR   HGNC; HGNC:2559; CXADR.
DR   HPA; ENSG00000154639; Low tissue specificity.
DR   MIM; 602621; gene.
DR   neXtProt; NX_P78310; -.
DR   OpenTargets; ENSG00000154639; -.
DR   PharmGKB; PA27055; -.
DR   VEuPathDB; HostDB:ENSG00000154639; -.
DR   eggNOG; ENOG502QSG0; Eukaryota.
DR   GeneTree; ENSGT00940000154829; -.
DR   HOGENOM; CLU_040549_0_0_1; -.
DR   InParanoid; P78310; -.
DR   OMA; CQFTLAP; -.
DR   OrthoDB; 896005at2759; -.
DR   PhylomeDB; P78310; -.
DR   TreeFam; TF330875; -.
DR   PathwayCommons; P78310; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   SignaLink; P78310; -.
DR   BioGRID-ORCS; 1525; 39 hits in 1053 CRISPR screens.
DR   ChiTaRS; CXADR; human.
DR   EvolutionaryTrace; P78310; -.
DR   GeneWiki; Coxsackie_virus_and_adenovirus_receptor; -.
DR   GenomeRNAi; 1525; -.
DR   Pharos; P78310; Tbio.
DR   PRO; PR:P78310; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; P78310; protein.
DR   Bgee; ENSG00000154639; Expressed in nipple and 199 other tissues.
DR   Genevisible; P78310; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; ISS:UniProtKB.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0044297; C:cell body; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:CACAO.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB.
DR   GO; GO:0086082; F:cell adhesive protein binding involved in AV node cell-bundle of His cell communication; IC:BHF-UCL.
DR   GO; GO:0071253; F:connexin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:0086067; P:AV node cell to bundle of His cell communication; ISS:UniProtKB.
DR   GO; GO:0086072; P:AV node cell-bundle of His cell adhesion involved in cell communication; ISS:BHF-UCL.
DR   GO; GO:0055013; P:cardiac muscle cell development; ISS:UniProtKB.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045216; P:cell-cell junction organization; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IDA:UniProtKB.
DR   GO; GO:0010669; P:epithelial structure maintenance; IMP:UniProtKB.
DR   GO; GO:0046629; P:gamma-delta T cell activation; ISS:UniProtKB.
DR   GO; GO:0008354; P:germ cell migration; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0034109; P:homotypic cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IMP:UniProtKB.
DR   GO; GO:0098904; P:regulation of AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0070633; P:transepithelial transport; IMP:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR013151; Immunoglobulin.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction;
KW   Immunoglobulin domain; Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Secreted; Signal; Tight junction;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..365
FT                   /note="Coxsackievirus and adenovirus receptor"
FT                   /id="PRO_0000014739"
FT   TOPO_DOM        20..237
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        238..258
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        259..365
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..134
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          141..228
FT                   /note="Ig-like C2-type 2"
FT   REGION          269..343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           360..365
FT                   /note="PDZ-binding"
FT   COMPBIAS        269..285
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        286..330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97792"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97792"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97792"
FT   LIPID           259
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:12021372"
FT   LIPID           260
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:12021372"
FT   CARBOHYD        106
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        201
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        41..120
FT                   /evidence="ECO:0000269|PubMed:10567268,
FT                   ECO:0000269|PubMed:11080637, ECO:0000269|PubMed:14967025"
FT   DISULFID        162..212
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:14967025"
FT   VAR_SEQ         71..89
FT                   /note="IILYSGDKIYDDYYPDLKG -> GRCATSKEPYVHCQKLHRQ (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014819"
FT   VAR_SEQ         90..365
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014820"
FT   VAR_SEQ         139
FT                   /note="V -> GKMCHLQRAVRPLPEATSAVIIHPWGPCLLPTWKDIPRLSITKYQVK
FT                   TLNALLRVRLSHLLR (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014821"
FT   VAR_SEQ         140..365
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014822"
FT   VAR_SEQ         191..232
FT                   /note="EMTSSVISVKNASSEYSGTYSCTVRNRVGSDQCLLRLNVVPP -> A (in
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_047729"
FT   VAR_SEQ         191
FT                   /note="E -> GKMCHLQRAVRPLPEATSAVIIHPWGPCLLPTWKDIPRLSITKYQVK
FT                   TLNALLRVRLSHLLR (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014823"
FT   VAR_SEQ         192..365
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14978041"
FT                   /id="VSP_014824"
FT   VAR_SEQ         340..365
FT                   /note="VAAPNLSRMGAIPVMIPAQSKDGSIV -> FKYPYKTDGITVV (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047357"
FT   VAR_SEQ         340..345
FT                   /note="VAAPNL -> FKYPY (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.8"
FT                   /id="VSP_014825"
FT   VAR_SEQ         346..365
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.8"
FT                   /id="VSP_014826"
FT   VARIANT         323
FT                   /note="S -> R (in dbSNP:rs34727960)"
FT                   /id="VAR_049871"
FT   MUTAGEN         70..72
FT                   /note="VII->AID: Abolishes binding to adenovirus type 5."
FT                   /evidence="ECO:0000269|PubMed:10666333"
FT   MUTAGEN         259..260
FT                   /note="CC->AA: Loss of palmitoylation and altered
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:12021372"
FT   MUTAGEN         318
FT                   /note="Y->A: Affects basolateral localization in airway
FT                   epithelial cells."
FT                   /evidence="ECO:0000269|PubMed:11316797"
FT   MUTAGEN         345..348
FT                   /note="LSRM->AAAA: Affects basolateral localization in
FT                   airway epithelial cells."
FT                   /evidence="ECO:0000269|PubMed:11316797"
FT   STRAND          21..32
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          37..39
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          53..61
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:1RSF"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   TURN            86..90
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   HELIX           98..100
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   HELIX           112..114
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          116..124
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          127..138
FT                   /evidence="ECO:0007829|PDB:1EAJ"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          156..163
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          171..178
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   HELIX           185..192
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          195..201
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          208..215
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   STRAND          221..227
FT                   /evidence="ECO:0007829|PDB:2NPL"
FT   CONFLICT        P78310-2:343
FT                   /note="P -> A (in Ref. 14; AAD31772)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   365 AA;  40030 MW;  AB01C6346CB7FE64 CRC64;
     MALLLCFVLL CGVVDFARSL SITTPEEMIE KAKGETAYLP CKFTLSPEDQ GPLDIEWLIS
     PADNQKVDQV IILYSGDKIY DDYYPDLKGR VHFTSNDLKS GDASINVTNL QLSDIGTYQC
     KVKKAPGVAN KKIHLVVLVK PSGARCYVDG SEEIGSDFKI KCEPKEGSLP LQYEWQKLSD
     SQKMPTSWLA EMTSSVISVK NASSEYSGTY SCTVRNRVGS DQCLLRLNVV PPSNKAGLIA
     GAIIGTLLAL ALIGLIIFCC RKKRREEKYE KEVHHDIRED VPPPKSRTST ARSYIGSNHS
     SLGSMSPSNM EGYSKTQYNQ VPSEDFERTP QSPTLPPAKV AAPNLSRMGA IPVMIPAQSK
     DGSIV
//
